Maplight Therapeutics Inc (MPLT)
SG&A Expense Growth
113.09%
Fiscal year · Period ending:
MPLT SG&A Expense Growth
Latest reported113.09%period ending
Latest reported113.09%period ending
MPLT FY SG&A Growth (YoY) (0.00% → 113.09%)
Latest values, visible window
High-resolution chart · PNG
MPLT sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 113.0902% | |
| 89.6017% | |
| 85.4913% | |
| 0% |